AMINOSYN II 8.5% W/ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic
NDAINJECTIONINJECTABLE
Approved
Apr 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN II 8.5% W/ELECTROLYTES is a parenteral nutrition formulation containing amino acids, magnesium chloride, potassium chloride, sodium chloride, and sodium phosphate dibasic administered by injection. It is designed to provide essential amino acids and electrolytes for patients requiring intravenous nutritional support who cannot maintain adequate intake orally or enterally. This product supports protein synthesis and electrolyte balance in critically ill or post-operative patients.
LOE Approaching
As an established generic-like injectable approaching loss of exclusivity, this product operates in a stable but increasingly commoditized market with modest commercial teams focused on hospital contracts and formulary management.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN II offers stability in a mature market but limited growth trajectory; roles emphasize vendor relationships, formulary management, and operational efficiency rather than product innovation. This is ideal for professionals seeking steady work in healthcare logistics and hospital systems, but may present fewer advancement opportunities than growth-stage products.
Hospital Account Manager
Worked on AMINOSYN II 8.5% W/ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.